Medtronic, Inc. (MDT) Tops Q4 EPS by 1c; Guides FY13 Sales
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $90.58 -0.2%
EPS Growth %: +10.3%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
OFLX, VAXX, NMRD, More
EPS Growth %: +10.3%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q4 EPS of $0.99, $0.01 better than the analyst estimate of $0.98. Revenue for the quarter came in at $4.3 billion versus the consensus estimate of $4.23 billion.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Medtronic, Inc. sees FY2013 EPS of $3.62-$3.70, versus the consensus of $3.66. Sees sales up 2-4 percent.
For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Innovaro (INV) Misses Q2 EPS by 9c
- zSpace, Inc. (ZSPC) Reports Q2 results
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
